公开(公告)号：KR1020130057744A

公开(公告)日：2013-06-03

申请号：KR1020110123642

申请日：2011-11-24

Applicant: 숭실대학교산학협력단

Inventor： 주상우 ,  서지혜 ,  이소영 ,  조근창

IPC: A61K33/38 ,  A61K33/08 ,  A61P35/00

Abstract: PURPOSE: A cancer therapeutic composition is provided to selectively damage cancer cells by irradiating visible light with a wavelength of 450 nm or greater and to treat cancer without a complex anticancer treatment. CONSTITUTION: A cancer therapeutic composition contains Ag/AgBr/TiO2 nanoparticles which damage cancer cells under visible light with a wavelength of 450-800 nm. The cancer includes uterine cervix cancer or skin cancer. The content of Ag in the nanoparticles is 1.35-3.41%. The nanoparticle is prepared by a deposition and precipitation method.

Abstract translation: 目的：提供癌症治疗组合物，通过照射450nm或更大波长的可见光来选择性地损伤癌细胞，并且在没有复杂的抗癌治疗的情况下治疗癌症。 构成：癌症治疗组合物含有Ag / AgBr / TiO2纳米颗粒，其在450-800nm波长的可见光下损伤癌细胞。 癌症包括子宫颈癌或皮肤癌。 纳米颗粒中Ag的含量为1.35〜3.41％。 纳米颗粒通过沉积和沉淀法制备。